Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duac Gel vs Differin Gel in Mild to Moderate Acne Vulgaris
NCT00160394Phase 4Completed
- Sponsor
- GSK
- Start
- Dec 2004
- Primary completion
- Aug 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, single-blind trial of Duac Gel / Differin Gel in acne vulgaris (2 arms), sponsored by GSK. Primary endpoint: Percentage change from baseline of inflammatory lesion counts at 2 weeks. Started Dec 2004; status: completed.
02
Drugs
Duac Gel / Differin Gel
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT00160394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00160394.